Extracorporeal Photochemotherapy in the Treatment of Severe Graft-Versus-Host Disease

Advances in posttransplanl immunosuppression have to the present not been able to prevent the development of graft-versus-host disease (GVHD) in patients given related or unrelated stem cell grafts for cure of hematologic diseases. Patients with GVHD not responding to first line therapy with corticosteroids remain at high risk of death due to severe infections or organ failure. Extracorporeal exposure of peripheral blood mononuclear cells to the photosensitizing agent 8-methoxypsoralen and ultraviolet A radiation has been shown to be effective in treatment of selected T-cell mediated diseases, including cutaneous T-cell lymphoma and rejection after organ transplantation. Extracorporeal photochemotherapy (ECP) is also a safe and efficacious adjunct therapy for both acute and chronic extensive GVHD with skin and visceral involvement and resistance to conventional immunosuppressive therapy. A multi-center randomized study should help define the impact of ECP in the treatment of GVHD and overall survival of these patients.

[1]  J. Apperley,et al.  Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD) , 1999, Bone Marrow Transplantation.

[2]  B. Griffith,et al.  Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. , 1998, The New England journal of medicine.

[3]  H. Hönigsmann,et al.  Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. , 1998, Blood.

[4]  G. Dini,et al.  Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. , 1998, Blood.

[5]  A. Nademanee,et al.  Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. , 1998, Blood.

[6]  R. Edelson,et al.  Photoactivated 8‐methoxypsoralen treatment causes a peptide‐dependent increase in antigen display by transformed lymphocytes , 1998, International journal of cancer.

[7]  J. Ferrara.  The cytokine modulation of acute graft-versus-host disease. , 1998, Bone marrow transplantation.

[8]  G. Zacchello,et al.  Treatment of graft-versus-host disease with photopheresis. , 1998, Transplantation.

[9]  C Anasetti,et al.  Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia. , 1998, The New England journal of medicine.

[10]  O. Haas,et al.  Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors , 1998, Bone Marrow Transplantation.

[11]  M. Weinstein,et al.  Unrelated Donor Bone Marrow Transplantation for Chronic Myelogenous Leukemia: A Decision Analysis , 1997, Annals of Internal Medicine.

[12]  M. Aringer,et al.  Photopheresis treatment enhances CD95 (fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis. , 1997, British Journal of Rheumatology.

[13]  B. Mahé,et al.  Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study. , 1997, Transplantation.

[14]  J. Klein,et al.  IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE , 1997, British journal of haematology.

[15]  F. Locatelli,et al.  Photopheresis in paediatric patients with drug‐resistant chronic graft‐versus‐host disease , 1997, British journal of haematology.

[16]  S. Okamoto.  [Bone marrow transplants from unrelated donors]. , 1997, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[17]  S. Yong,et al.  Extracorporeal Photochemotherapy (Photopheresis) Induces Apoptosis in Lymphocytes: A Possible Mechanism of Action of PUVA Therapy , 1997, Photochemistry and photobiology.

[18]  B. Balda,et al.  Treatment of cutaneous T‐cell lymphoma with extracorporeal photochemotherapy , 1996 .

[19]  B. Balda,et al.  Extracorporeal photochemotherapy as an effective treatment modality in chronic graft-versus-host disease , 1996 .

[20]  F. Gasparro,et al.  Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action. , 1996, The Journal of investigative dermatology.

[21]  A. Nagler,et al.  Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. , 1996, Blood.

[22]  F. Zacchello,et al.  Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease. , 1995, Transplantation.

[23]  S. Lessin,et al.  Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. , 1994, Artificial organs.

[24]  I. Sniecinski.  Extracorporeal photochemotherapy: a scientific overview. , 1994, Transfusion science.

[25]  W. Siegert,et al.  Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. , 1994, Bone marrow transplantation.

[26]  H. Deeg,et al.  Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. , 1994, Blood.

[27]  M. Groß,et al.  EXTRACORPOREAL PHOTOPHERESIS , 1994, International journal of dermatology.

[28]  G. Hale,et al.  Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases. , 1994, Bone marrow transplantation.

[29]  P. Hervé.  Prevention and treatment of acute GvHD--new modalities. , 1993, Nouvelle revue francaise d'hematologie.

[30]  F. Trautinger,et al.  Parenteral administration of 8-methoxypsoralen in photopheresis. , 1993, Journal of the American Academy of Dermatology.

[31]  J. Ferrara,et al.  Cytokine dysregulation and acute graft-versus-host disease. , 1992, Blood.

[32]  H. Deeg,et al.  Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia [letter] , 1992 .

[33]  L. Walsh,et al.  Extracorporeal Photochemotherapy Induces the Production of Tumor Necrosis Factor-α by Monocytes: Implications for the Treatment of Cutaneous T-Cell Lymphoma and Systemic Sclerosis , 1992 .

[34]  S. Jimenez,et al.  Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. , 1992, Archives of dermatology.

[35]  F. Trautinger,et al.  Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus. A pilot study. , 1992, Arthritis and rheumatism.

[36]  R. Storb,et al.  A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment. , 1990, Blood.

[37]  H. Hönigsmann,et al.  Photochemotherapy improves chronic cutaneous graft-versus-host disease. , 1990, Journal of the American Academy of Dermatology.

[38]  J. Sprent,et al.  Role of T cell subsets in lethal graft-versus-host disease (GVHD) directed to class I versus class II H-2 differences. II. Protective effects of L3T4+ cells in anti-class II GVHD. , 1990, Journal of immunology.

[39]  J. Garro,et al.  Engineering aspects of extracorporeal photochemotherapy. , 1989, The Yale journal of biology and medicine.

[40]  B. Blazar,et al.  T cell depletion for graft-versus-host-disease prophylaxis. A perspective on engraftment in mice and humans. , 1989, Transplantation.

[41]  H. Deeg,et al.  Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. , 1988, Blood.

[42]  Jean E. Sanders,et al.  Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. , 1988, Blood.

[43]  K Wolff,et al.  Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. , 1987, The New England journal of medicine.

[44]  H. Deeg,et al.  Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. , 1986, The New England journal of medicine.

[45]  R. Storb,et al.  Marrow transplantation from related donors other than HLA-identical siblings. , 1985, The New England journal of medicine.

[46]  R. Storb,et al.  Treatment of graft‐versus‐host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids , 1981, American journal of hematology.

[47]  R. Storb,et al.  Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft-versus-host disease in recipients of allogeneic marrow grafts. , 1978, Transplantation proceedings.

[48]  R Storb,et al.  Bone-marrow transplantation (first of two parts). , 1975, The New England journal of medicine.

[49]  P. Neiman,et al.  CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.

[50]  T. Ruzicka,et al.  Extracorporeal photopheresis in the treatment of acute graft-versus-host disease. , 1997, Journal of the American Academy of Dermatology.

[51]  R. Clift.  Marrow transplantation for chronic myeloid leukemia. , 1995, Cancer treatment and research.

[52]  P. Hilliquin,et al.  Extracorporeal photochemotherapy. , 1992, British journal of rheumatology.

[53]  H. Deeg,et al.  Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia. , 1992, Blood.

[54]  K. Sullivan,et al.  A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment. , 1990, Blood.

[55]  R. Nuscher,et al.  Bone marrow transplantation. , 1977, The American journal of nursing.

[56]  Billingham Re.  The biology of graft-versus-host reactions. , 1966 .